[PCRX] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[PCRX] Pacira BioSciences, Inc.
Announcement Date
04-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- 233.13%
YoY- -34.15%
Quarter Report
PCRX's Result
PCRX's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 171,955 167,466 169,411 157,991 159,194 127,722 135,590 17.11%
PBT -18,068 2,069 22,007 7,294 -6,197 24,231 25,648 -
Tax -7,966 2,762 2,131 466 -1,068 6,571 6,567 -
NP -10,102 -693 19,876 6,828 -5,129 17,660 19,081 -
Tax Rate - -133.49% -9.68% -6.39% - -27.12% -25.60% -
Total Cost 182,057 168,159 149,535 151,163 164,323 110,062 116,509 34.54%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin -5.87 -0.41 11.73 4.32 -3.22 13.83 14.07 -
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -0.22 -0.02 0.40 0.15 -0.12 0.40 0.43 -
EPS Diluted -0.22 -0.02 0.38 0.15 -0.12 0.39 0.42 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.